The gene set enrichment analysis based on the TCGA database shows that the high expression of AGAP2-AS1 may be an independent predictor of the low survival rate of ccRCC patients [18], but experiments have not confirmed this. Here, AGAP2 is linked to nonpapillary renal cell carcinoma.